Trial Profile
Window of Opportunity Trial of Neoadjuvant ADXS 11-001 Vaccination Prior to Robot -Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2022
Price :
$35
*
At a glance
- Drugs Axalimogene filolisbac (Primary)
- Indications Oropharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions; Pharmacodynamics
- 09 Sep 2022 Status changed from active, no longer recruiting to completed.
- 27 Mar 2020 Status changed from recruiting to active, no longer recruiting.
- 20 Mar 2019 Planned End Date changed from 1 Aug 2021 to 1 Aug 2023.